Zeke Capital Advisors, LLC Uro Gen Pharma Ltd. Transaction History

Zeke Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$5.12 - $8.74 $921,600 - $1.57 Million	-180,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.92 - $9.73 $2.45 Million - $4.02 Million	-413,656 Reduced 69.68%	180,000 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $1.17 Million - $2.49 Million	-130,021 Reduced 17.97%	593,656 $5.65 Million
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $11,476 - $14,748	802 Added 0.11%	723,677 $12.2 Million
Q2 2021 Aug 16, 2021	BUY	$15.2 - $20.94 $3.13 Million - $4.31 Million	205,769 Added 39.79%	722,875 $11 Million
Q1 2021 Apr 21, 2021	BUY	$17.99 - $26.96 $9.3 Million - $13.9 Million	517,106 New	517,106 $10.1 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Zeke Capital Advisors, LLC with notifications on news.